(202) 599-8435

CLAAD To Participate in CBI’s Abuse-Deterrent Formulations Summit

Washington, D.C. – January 10, 2017 – The Center for Lawful Access and Abuse Deterrence (CLAAD) will participate in CBI’s 3rd Abuse-Deterrent Formulations Summit next Wednesday in Alexandria, Virginia. Participants will engage in forward-thinking discussions surrounding the evolving regulatory requirements of abuse-deterrent formulations for both branded and generic opioid medications.

The conference will take place on March 7 and 8 at the Embassy Suites in Alexandria, Virginia.

Print Friendly, PDF & Email
About the Author